National Healthcare Corp (NHC): who owns it and who trades it
As of Nov 16, 2026, NHC insiders reported 22 open-market sales worth $10.4M and 1 purchase worth $175K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Emil E Hassan (Director), with $2.5M. 3 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling National Healthcare
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns NHC
249 funds and institutions reported NHC shares worth $2.2B at the end of Q2 2026, about 67% of the company. The largest holder is BlackRock, Inc. with 12.6%.
Funds and institutions (13F) 67%Everyone else 33%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 1.98M | 12.65% | $418M | +4% |
| Morgan Stanley Institutional Investment Advisors LLC | 1.03M | 6.58% | $217M | -1% |
| Dimensional Fund Advisors LP | 929,692 | 5.95% | $196M | -2% |
| Vanguard Portfolio Management LLC | 809,224 | 5.18% | $171M | +3% |
| First Trust Advisors LP | 730,573 | 4.68% | $154M | +38% |
| Vanguard Capital Management LLC | 552,136 | 3.53% | $117M | +0% |
| State Street Corp | 526,732 | 3.37% | $112M | +7% |
| Geode Capital Management, LLC | 380,934 | 2.44% | $80.5M | +18% |
| Renaissance Technologies LLC | 299,717 | 1.92% | $63.3M | -11% |
| Invesco Ltd. | 175,290 | 1.12% | $37M | +17% |
| Charles Schwab Investment Management Inc | 174,335 | 1.12% | $36.8M | -2% |
| Sixth Street Partners Management Company, L.P. | 174,335 | 1.12% | $36.8M | – |
| Northern Trust Corp | 145,179 | 0.93% | $30.7M | +6% |
| Bank of New York Mellon Corp | 122,320 | 0.78% | $25.9M | +2% |
| Systematic Financial Management LP | 109,086 | 0.70% | $23.1M | -6% |
| T. Rowe Price Investment Management, Inc. | 107,248 | 0.69% | $22.7M | – |
| Arrowstreet Capital, Limited Partnership | 96,550 | 0.62% | $20.4M | +28% |
| Morgan Stanley | 93,536 | 0.60% | $19.8M | -13% |
| American Century Companies Inc | 92,933 | 0.59% | $19.6M | +4% |
| Alps Advisors Inc | 87,660 | 0.56% | $18.5M | -44% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, NHC insiders reported $175K of open-market purchases and $10.4M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Vicki L Dodson | Vice president | Sale | 4,834 | $225.00 | $1.1M | Form 4 |
| Sep 11, 2026 | Brian F Kidd | CFO | Sale | 6,813 | $225.70 | $1.5M | Form 4 |
| Sep 10, 2026 | Josh A McCreary | Vice president | Sale | 1,291 | $225.09 | $291K | Form 4 |
| Sep 10, 2026 | Josh A McCreary | Vice president | Sale | 789 | $223.78 | $177K | Form 4 |
| Sep 10, 2026 | Josh A McCreary | Vice president | Sale | 571 | $222.73 | $127K | Form 4 |
| Sep 10, 2026 | Josh A McCreary | Vice president | Sale | 68 | $225.59 | $15.3K | Form 4 |
| Aug 28, 2026 | Ben Anderson Flatt Sr | Vice president | Sale | 1,000 | $222.50 | $222K | Form 4 |
| Aug 25, 2026 | Ben Anderson Flatt Sr | Vice president | Sale | 1,000 | $227.00 | $227K | Form 4 |
| Aug 25, 2026 | David R. Gifford | Director | Sale | 1,779 | $225.42 | $401K | Form 4 |
| Aug 20, 2026 | Ben Anderson Flatt Sr | Vice president | Sale | 1,000 | $237.00 | $237K | Form 4 |
| Aug 19, 2026 | Ben Anderson Flatt Sr | Vice president | Sale | 1,000 | $237.18 | $237K | Form 4 |
| Aug 19, 2026 | Stephen Fowler Flatt | CEO | Sale | 1,500 | $237.08 | $356K | Form 4 |
| Aug 17, 2026 | Ben Anderson Flatt Sr | Vice president | Sale | 1,000 | $226.00 | $226K | Form 4 |
| Aug 14, 2026 | Ben Anderson Flatt Sr | Vice president | Sale | 1,000 | $222.11 | $222K | Form 4 |
| Aug 12, 2026 | Ben Anderson Flatt Sr | Vice president | Sale | 1,000 | $221.21 | $221K | Form 4 |
| Jun 22, 2026 | Emil E Hassan | Director | Sale | 5,937 | $200.00 | $1.2M | Form 4 |
| Jun 16, 2026 | Emil E Hassan | Director | Sale | 1,563 | $199.98 | $313K | Form 4 |
| Jun 1, 2026 | Lisa Piercey | Director | Purchase | 949 | $184.26 | $175K | Form 4 |
| May 21, 2026 | Richard F Laroche Jr | Director | Sale | 7,500 | $195.14 | $1.5M | Form 4 |
| May 19, 2026 | Timothy J. Shelly | Vice president | Sale | 1,853 | $197.22 | $365K | Form 4 |
| Dec 17, 2025 | Timothy J. Shelly | Vice president | Sale | 2,454 | $139.42 | $342K | Form 4 |
| Nov 25, 2025 | Emil E Hassan | Director | Sale | 7,500 | $138.52 | $1M | Form 4 |
| Nov 21, 2025 | Stephen Fowler Flatt | CEO | Sale | 1,000 | $130.33 | $130K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Emil E Hassan | Director | – | $2.5M | Jun 22, 2026 |
| Ben Anderson Flatt Sr | Senior VP & CIO | – | $1.6M | Aug 28, 2026 |
| Brian F Kidd | SVP, CFO | – | $1.5M | Sep 11, 2026 |
| Richard F Laroche Jr | Director | – | $1.5M | May 21, 2026 |
| Vicki L Dodson | Sr.VP Patient Srvcs | – | $1.1M | Sep 22, 2026 |
| Timothy J. Shelly | Sr.VP Operations | – | $708K | May 19, 2026 |
| Josh A McCreary | Senior VP & General Counsel | – | $610K | Sep 10, 2026 |
| Stephen Fowler Flatt | CEO, Director | – | $486K | Aug 19, 2026 |
| David R. Gifford | Director | – | $401K | Aug 25, 2026 |
| Lisa Piercey | Director | $175K | – | Jun 1, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
NHC short interest
Low short interest. 4.9% of NHC shares are sold short: about 1 share in 20. Over the last 12 reports the number of shares short went up 21%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 769,712 NHC shares were sold short, 4.9% of the shares outstanding, up 1.9% from the report before. At the average daily volume of 172,979 shares, buying them all back would take about 4.5 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 769,712 | 4.91% | +2% | 172,979 | 4.5 |
| Oct 15, 2026 | 755,039 | 4.82% | -8% | 84,624 | 8.9 |
| Sep 30, 2026 | 817,160 | 5.22% | +20% | 132,770 | 6.2 |
| Sep 15, 2026 | 683,175 | 4.36% | -9% | 81,861 | 8.3 |
| Aug 31, 2026 | 746,799 | 4.77% | -1% | 102,929 | 7.3 |
| Aug 14, 2026 | 756,850 | 4.83% | +1% | 129,254 | 5.9 |
| Jul 31, 2026 | 747,974 | 4.79% | +5% | 102,613 | 7.3 |
| Jul 15, 2026 | 713,058 | 4.57% | -10% | 111,419 | 6.4 |
| Jun 30, 2026 | 790,113 | 5.06% | +43% | 223,641 | 3.5 |
| Jun 15, 2026 | 552,921 | 3.54% | -7% | 123,012 | 4.5 |
| May 29, 2026 | 594,600 | 3.81% | -7% | 111,519 | 5.3 |
| May 15, 2026 | 635,979 | 4.07% | -8% | 92,369 | 6.9 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
National Healthcare company events
National Healthcare filed 14 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 6, 2026.
- Nov 6, 2026ResultsReleased financial results. Filing
- Nov 6, 2026AnnouncementNHC issued a press release on November 5, 2026, announcing its quarterly common dividend. Filing
- Aug 11, 2026AnnouncementNHC issued a press release on August 6, 2026, announcing its quarterly common dividend. Filing
- Aug 11, 2026ResultsReleased financial results. Filing
- Jul 1, 2026DealThe information set forth in the Introductory Note to this report and in Item 1.01 of the April 21st Current Report is incorporated by reference into this Item 2.01 to the extent such information is responsive to the disclosure requirements of Item 2.01 of Current Report on Form 8-K. The Purchase… Filing
- May 27, 2026AgreementNational HealthCare Corporation entered into a Credit Agreement among NHC, as borrower, certain subsidiaries of NHC, as the guarantors, the lenders from time to time party thereto, and Bank of America, N.A., as administrative agent, swingline lender and issuer of letters of credit. Filing
- May 15, 2026AgreementNHC/OP, L.P., a Delaware limited partnership and a wholly-owned subsidiary of National HealthCare Corporation, entered into a Purchase and Sale Agreement with National Health Corporation, a Tennessee corporation, to purchase from Seller the land, buildings, and other specified assets of Seller’s… Filing
- May 13, 2026VoteReported shareholder vote results. Filing
- May 8, 2026ResultsReleased financial results. Filing
- May 7, 2026AnnouncementNHC issued a press release on May 7, 2026, announcing its quarterly common dividend. Filing
- Apr 22, 2026AgreementNHC/OP, L.P., a Delaware limited partnership and a wholly-owned subsidiary of National HealthCare Corporation, on behalf of itself and its affiliates identified in the Agreement, each of which is a wholly-owned subsidiary of NHC (collectively, together with the Purchaser, “we,” “us,” or “our”)… Filing
- Feb 27, 2026ResultsReleased financial results. Filing
- Feb 17, 2026LeadershipThe Board of Directors of National HealthCare Corporation, upon the recommendation of the Nominating and Corporate Governance Committee of the Board and by unanimous vote of the Board, increased the size of the Board by two (2) directors to a total of nine (9) directors effective February 12, 2026… Filing
- Feb 13, 2026AnnouncementNHC issued a press release on February 13, 2026, announcing its quarterly common dividend. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
National Healthcare financials
Famous investors that hold NHC
3 of the 50 well-known investors we track reported holding NHC in their latest 13F filing. The largest position is Jim Simons's, worth $57.8M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 263,117 | $57.8M | 0.1% | -12% |
| Israel Englander · Millennium Management | Q3 2026 | 5,675 | $1.2M | 0.0% | New |
| Jeremy Grantham · GMO | Q3 2026 | 1,666 | $366K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named NHC in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 30, 2026 | First Trust Portfolios L.P. | 13G/A | 4.6% |
| Oct 30, 2026 | First Trust Portfolios L.P. | 13G/A | 4.6% |
Questions about National Healthcare Corp (NHC) stock
Who owns the most NHC stock?
The largest reported owner of National Healthcare Corp (NHC) is BlackRock, Inc., with 12.6% of the company. In total, 249 funds and institutions reported holding NHC at the end of Q2 2026, together about 67% of the shares. See the largest owners.
Are NHC insiders buying or selling?
In the last 12 months, NHC insiders reported 1 open-market purchase worth $175K and 22 sales worth $10.4M. The latest trade was on Sep 22, 2026. See every trade.
What is the short interest in NHC?
As of Oct 30, 2026, 769,712 NHC shares were sold short, 4.9% of the shares outstanding, up 1.9% from the report before. At the average daily volume of 172,979 shares, buying them all back would take about 4.5 trading days (days to cover). See the history.
Which famous investors hold NHC?
3 of the 50 well-known investors we track reported NHC in their latest 13F filing, including Jim Simons, Israel Englander, Jeremy Grantham. The largest position is worth $57.8M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.